| Name | Title | Contact Details |
|---|---|---|
Anna Asberg |
SVP IT and global CIO | Profile |
Allison Sands |
Vice President Corporate Security and | Profile |
Marc Berson |
Senior Vice President and Chief Information Officer | Profile |
Bill Merritt |
Principal IT Security Architect, Security and Privacy | Profile |
Varun Goel |
IT Security and Risk Associate Director | Profile |
Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well certain genetic diseases such as polycystic kidney disease.
Lumate Health is a Cognitive Behavioral Teletherapy Platform treating teenagers and young adults with anxiety-related mental health disorders.
HatchMed - Bringing user centric design into the medical equipment world https://t.co/7vuyMSBnct #hospital #nurseproof #Seattle